{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:50:44Z","timestamp":1765889444585,"version":"3.40.4"},"reference-count":30,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,1,3]]},"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1183\/23120541.01262-2024","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T15:25:15Z","timestamp":1737645915000},"page":"01262-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["ERS Congress 2024: highlights from the Respiratory Infections Assembly"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-495X","authenticated-orcid":false,"given":"Leander","family":"Jonckheere","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-0842","authenticated-orcid":false,"given":"Efthymia","family":"Papadopoulou","sequence":"additional","affiliation":[]},{"given":"Federica","family":"Piedepalumbo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-9260","authenticated-orcid":false,"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-3099","authenticated-orcid":false,"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Chiara","family":"Premuda","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025041402453973000_11.2.01262-2024.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00692-8"},{"key":"2025041402453973000_11.2.01262-2024.2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00014-09"},{"key":"2025041402453973000_11.2.01262-2024.3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0043-1777259","article-title":"Aspergillus and the lung","volume":"45","author":"Janssens","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"2025041402453973000_11.2.01262-2024.4","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myv020"},{"key":"2025041402453973000_11.2.01262-2024.5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0043-1776997","article-title":"Antifungal resistance in pulmonary aspergillosis","volume":"45","author":"Verweij","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"2025041402453973000_11.2.01262-2024.6","doi-asserted-by":"crossref","first-page":"e0007423","DOI":"10.1128\/cmr.00074-23","article-title":"Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease","volume":"37","author":"Hoenigl","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"2025041402453973000_11.2.01262-2024.7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01611-0"},{"key":"2025041402453973000_11.2.01262-2024.8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5588\/ijtld.21.0185","article-title":"Chronic pulmonary aspergillosis as a sequel to pulmonary TB","volume":"25","author":"Salzer","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025041402453973000_11.2.01262-2024.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30309-3"},{"key":"2025041402453973000_11.2.01262-2024.10","unstructured":"World Health Organization . Global tuberculosis report 2022. Geneva, World Health Organization, 2022. https:\/\/iris.who.int\/bitstream\/handle\/10665\/363752\/9789240061729-eng.pdf"},{"key":"2025041402453973000_11.2.01262-2024.11","doi-asserted-by":"crossref","unstructured":"World Health Organization . Key updates to the treatment of drug-resistant tuberculosis: rapid communication, June 2024. Geneva, World Health Organization, 2024. https:\/\/doi.org\/10.2471\/B09123","DOI":"10.2471\/B09123"},{"key":"2025041402453973000_11.2.01262-2024.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.105938"},{"key":"2025041402453973000_11.2.01262-2024.13","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2608-5"},{"key":"2025041402453973000_11.2.01262-2024.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119430"},{"key":"2025041402453973000_11.2.01262-2024.15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(23)00389-2","article-title":"Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial","volume":"12","author":"Nyang'wa","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025041402453973000_11.2.01262-2024.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02029-2022"},{"key":"2025041402453973000_11.2.01262-2024.17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","article-title":"Multisystemic effects of elexacaftor-tezacaftor-ivacaftor in adults with cystic fibrosis and advanced lung disease","volume":"21","author":"Burgel","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2025041402453973000_11.2.01262-2024.18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(24)00208-X","article-title":"The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study","volume":"12","author":"Burgel","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025041402453973000_11.2.01262-2024.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202109-2121LE"},{"key":"2025041402453973000_11.2.01262-2024.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202011-4153OC"},{"key":"2025041402453973000_11.2.01262-2024.21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcf.2023.09.008","article-title":"Standards for the care of people with cystic fibrosis (CF): a timely and accurate diagnosis","volume":"22","author":"Castellani","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2025041402453973000_11.2.01262-2024.22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2025041402453973000_11.2.01262-2024.23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2025041402453973000_11.2.01262-2024.24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2025041402453973000_11.2.01262-2024.25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1163391"},{"key":"2025041402453973000_11.2.01262-2024.26","first-page":"37","article-title":"Cystic fibrosis in low and middle-income countries (LMIC): a view from four different regions of the world","volume":"38","author":"da Silva Filho","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"2025041402453973000_11.2.01262-2024.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01307-2022"},{"key":"2025041402453973000_11.2.01262-2024.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01581-2021"},{"key":"2025041402453973000_11.2.01262-2024.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202303-0458OC"},{"key":"2025041402453973000_11.2.01262-2024.30","doi-asserted-by":"crossref","unstructured":"Swenson CE , Hunt WR , Manfredi C , et al. Evaluating elexacaftor\/tezacaftor\/ivacaftor (ETI; TrikaftaTM) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFB): a clinical study protocol. medRxiv 2024; preprint [ https:\/\/doi.org\/10.1101\/2024.07.19.24310604 ].","DOI":"10.1101\/2024.07.19.24310604"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01262-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:45:50Z","timestamp":1744623950000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01262-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,14]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1183\/23120541.01262-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01262-2024","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2025,1,23]]}}}